CHOU2 PHARMA Partners with Ethos Discovery to Study Potential New Therapy for Canine Idiopathic Epilepsy

NARBERTH, Pa., Jan. 27, 2025 /PRNewswire/ — Chou2 Pharma LLC, a company focused on advancing the therapeutic use of cannabinoid molecules in veterinary medicine, is pleased to announce that the company has initiated a new study in partnership with Ethos Discovery to evaluate…